OncologySTAT Celebrates More Than 12,000 Registered Users, Including
20 Percent of U.S. Hematologists, Oncologists
Portal delivers news, journals, meeting coverage and clinical tools to
professionals, transforming how physicians access cancer information
online
Site also announces “Health on the Net”
certification
NEW YORK (Business Wire EON/PRWEB ) June 23, 2008 --
OncologySTAT (http://www.oncologystat.com),
the first subscription-free professional oncology portal from an
international scientific, technical and medical publisher, today
commemorated its 12,000th registered user.
Backed by the support of major healthcare and pharmaceutical companies,
OncologySTAT has emerged as one of the most trusted and trafficked
professional Web sites in the growing field of cancer care. Since its
launch in September 2007, the site has attracted more than 12,000
registrants, nearly 70 percent of whom are physicians or healthcare
professionals involved in cancer care, as well as more than 80,000
unique visitors and one million page views. More than 2,200 of
OncologySTAT’s registered users are U.S.-based
oncologists, representing a 20 percent-plus penetration of the U.S.
hematology/oncology physician audience.
“OncologySTAT has rapidly become a leading
online professional cancer resource for clinicians, researchers and
decision makers,” said Lee Schwartzberg, M.D.,
FACP, and OncologySTAT’s Editor-in-Chief. “It
offers users free access to an unprecedented collection of medical
journals, news, conference coverage and clinical tools, empowering
healthcare professionals to make more effective business and cancer care
decisions.”
Elsevier (http://www.elsevier.com),
the world’s leading provider of medical and
health education and information, provides content, technical and
business management for OncologySTAT. The portal provides instant access
to multiple professional cancer resources, including journals, books,
drug monographs, news and databases – in a
single online location.
In addition, the site is newly certified by the Health on the Net
Foundation (HON, http://www.HealthOnNet.org)
a non-profit, non-governmental organization accredited to the Economic
and Social Council (ECOSOC) of the United Nations that promotes and
guides the deployment of useful and reliable online medical and health
information, and its appropriate and efficient use.
Content Offerings Lead to Top Search Result Ranking
Upon registering, OncologySTAT users can search and download current
oncology-related, peer-reviewed articles from more than 100 Elsevier
journals or stay informed and up-to-date through features such as daily
industry news and regulatory updates, a comprehensive chemotherapy
regimens database, professional drug and interaction databases, and
weekly summaries of top oncology research findings from over 50
publications. All site content is organized by 29 cancer types, enabling
oncologists to instantly access the latest news and scientific updates
pertaining to their specialty.
“In less than one year of operation,
OncologySTAT regularly surfaces on the first page of organic search
results for Google ‘oncology’
searches,” says Monique Fayad, Senior Vice
President at Elsevier and Publisher. “This is
a direct result of the breadth and depth of free professional cancer
care content, plus complimentary access to oncology-related articles
from more than 100 Elsevier medical journals. No other site can compete
with the volume and quality of free unbiased information that
OncologySTAT provides to oncologists.”
OncologySTAT also provides cancer patients, survivors and caregivers −
who comprise 13 percent of the registered user base −
with access to the same information used by experienced cancer care
professionals. Among the site’s top
attractions are daily medical and regulatory news feeds from Elsevier’s
Global Medical News and the Pink Sheet Daily.
Dr. Prateek Mendiratta, a hematology/oncology fellow at Duke University
Medical Center, considers OncologySTAT “one
of the best sites available for the practicing or training oncologist.”
Dr. Mendiratta uses OncologySTAT approximately four times per week and
praises its rapid news updates, e-mail alerts, chemotherapy regimens and
free access to information regarding clinical trials and new
scientifically-based therapies. Dr. Mendiratta says, “OncologySTAT
aims to provide a centralized resource for the practicing oncologist. It
disseminates critical information in a concise, precise and effective
manner. We also have an opportunity to have a glimpse of what the
experts in the field are thinking and believe are important. Very few
sites out there are able to accomplish this as well as OncologySTAT.”
The OncologySTAT advisory board includes 10 of the most influential
names in oncology, including two past-presidents of the American Society
of Clinical Oncology (ASCO). The editorial team is led by Dr.
Schwartzberg, and includes a team of medical oncologists, professional
medical writers and oncology fellows.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with
the global science and health communities, Elsevier’s
7,000 employees in over 70 offices worldwide publish more than 2,000
journals and 1,900 new books per year, in addition to offering a suite
of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/),
MD Consult (http://www.mdconsult.com/),
Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/)
is a global business headquartered in Amsterdam, The Netherlands and has
offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/),
a world-leading publisher and information provider. Operating in the
science and medical, legal, education and business-to-business sectors,
Reed Elsevier provides high-quality and flexible information solutions
to users, with increasing emphasis on the Internet as a means of
delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1UaGlyLUxvdmUtUHJvZi1Qcm9mLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.